Revolution Medicines, Inc. (RVMD)
USD 42.97
(-4.85%)
USD 42.97
(-4.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -350.57 Million | -224.4 Million | -147.18 Million | -100.06 Million | -49.61 Million | 1.21 Million |
| Net Income | -436.36 Million | -248.7 Million | -187.09 Million | -108.15 Million | -47.66 Million | -41.78 Million |
| Depreciation & Amortization | 9.3 Million | 9.65 Million | 7.33 Million | 6.54 Million | 3.34 Million | 1.76 Million |
| Deferred income taxes | -3.91 Million | -419 Thousand | - | -375 Thousand | -4.37 Million | 201 Thousand |
| Stock-based compensation | 61.77 Million | 31.19 Million | 20.72 Million | 8.88 Million | 3.16 Million | 855 Thousand |
| Change in working capital | 40.66 Million | -13.48 Million | 8.72 Million | -8.3 Million | -8.82 Million | 38.06 Million |
| Other non-cash items | -22.03 Million | -2.64 Million | 3.13 Million | 1.34 Million | 4.74 Million | 2.12 Million |
| Investing Cash Flow | -342.59 Million | -24.11 Million | -142.11 Million | -234.23 Million | -101.96 Million | -1.33 Million |
| Investments in PPE | -7.72 Million | -10.81 Million | -6.52 Million | -2.93 Million | -2.58 Million | -1.49 Million |
| Acquisitions | 840.83 Million | 13.3 Million | 135.58 Million | 231.3 Million | 196 Thousand | 160 Thousand |
| Investment purchases | -1.05 Billion | -612.76 Million | -671.33 Million | -544.13 Million | -172.26 Million | - |
| Sales/Maturities of investments | 724.04 Million | 599.46 Million | 535.74 Million | 312.83 Million | 66.69 Million | - |
| Other Investing Activities | -840.83 Million | -13.3 Million | -135.58 Million | -231.3 Million | 6 Million | - |
| Financing Cash Flow | 1.22 Billion | 301.43 Million | 294.17 Million | 422.77 Million | 98.65 Million | 60.84 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 3.31 Million | 1.86 Million | 1.87 Million | 832 Thousand | -45 Thousand | -131 Thousand |
| Common Stock Issuance | 392.39 Million | 298.04 Million | 291.24 Million | 420.06 Million | 100.02 Million | 420 Thousand |
| Other Financing Activities | 833.49 Million | 1.52 Million | 1.06 Million | 1.87 Million | -1.32 Million | 60.42 Million |
| Accounts receivables | 3.41 Million | 1.25 Million | 464 Thousand | 2.34 Million | -1.43 Million | -7.3 Million |
| Accounts payables | 32.46 Million | 7.28 Million | 2.23 Million | 305 Thousand | 5.26 Million | 109 Thousand |
| Inventory | - | - | 7.68 Million | -2.34 Million | 1.43 Million | - |
| Other working capital | 4.77 Million | -22.03 Million | -1.66 Million | -8.6 Million | -14.09 Million | 37.95 Million |
| Cash at beginning of period | 161.41 Million | 110.23 Million | 105.35 Million | 16.87 Million | 69.8 Million | 9.07 Million |
| Cash at end of period | 696.14 Million | 163.14 Million | 110.23 Million | 105.35 Million | 16.87 Million | 69.8 Million |
| Capital Expenditure | -7.72 Million | -10.81 Million | -6.52 Million | -2.93 Million | -2.58 Million | -1.49 Million |
| Effect of forex changes on cash | -1.29 Million | - | - | - | - | - |
| Net cash flow / Change in cash | 534.73 Million | 52.91 Million | 4.88 Million | 88.47 Million | -52.92 Million | 60.72 Million |
| Free Cash Flow | -358.3 Million | -235.21 Million | -153.7 Million | -102.99 Million | -52.2 Million | -286 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -133.23 Million | -116 Million | -436.36 Million | -161.53 Million | -108.43 Million | -98.29 Million |
| Depreciation & Amortization | 2.79 Million | 2.76 Million | 9.3 Million | 2.85 Million | 2.14 Million | 1.77 Million |
| Deferred income taxes | - | - | -3.91 Million | -43 Thousand | -3.86 Million | - |
| Stock-based compensation | 19.77 Million | 16.2 Million | 61.77 Million | 25.42 Million | 13.66 Million | 12.98 Million |
| Change in working capital | -4.74 Million | -47.21 Million | 40.66 Million | 21.19 Million | -2.73 Million | 21.27 Million |
| Other non-cash items | -12.76 Million | 33.12 Million | -22.03 Million | -8.46 Million | -1.27 Million | -4.85 Million |
| Investing Cash Flow | 107.94 Million | -247.96 Million | -342.59 Million | -380.4 Million | 77.35 Million | -43.54 Million |
| Investments in PPE | -2.39 Million | -3.16 Million | -7.72 Million | -2.31 Million | -2.53 Million | -1.11 Million |
| Acquisitions | - | - | 840.83 Million | 884.05 Million | -79.88 Million | 42.42 Million |
| Investment purchases | -374.85 Million | -701.68 Million | -1.05 Billion | -519.6 Million | -170.03 Million | -176.17 Million |
| Sales/Maturities of investments | 485.19 Million | 456.88 Million | 724.04 Million | 141.52 Million | 249.92 Million | 133.75 Million |
| Other Investing Activities | 110.34 Million | -244.79 Million | -840.83 Million | -884.05 Million | 79.88 Million | -42.42 Million |
| Financing Cash Flow | 7.5 Million | 810 Thousand | 1.22 Billion | 839.35 Million | 1.01 Million | 64.63 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 3.16 Million | - | 3.31 Million | 3.31 Million | - | - |
| Common Stock Issuance | 7.5 Million | 810 Thousand | 392.39 Million | 2.54 Million | 1.01 Million | 62.05 Million |
| Other Financing Activities | 7.5 Million | 810 Thousand | 833.49 Million | 833.49 Million | 1.00 | 2.57 Million |
| Accounts receivables | - | 1.25 Million | 3.41 Million | -945 Thousand | 2.2 Million | 1.48 Million |
| Accounts payables | -4.08 Million | -28.96 Million | 32.46 Million | 24.3 Million | 580 Thousand | 8.63 Million |
| Inventory | - | - | - | -10.94 Million | -1.64 Million | 12.59 Million |
| Other working capital | -660 Thousand | -19.5 Million | 4.77 Million | 8.78 Million | -3.86 Million | -1.43 Million |
| Cash at beginning of period | 291.46 Million | 696.14 Million | 161.41 Million | 358.39 Million | 382.92 Million | 428.95 Million |
| Cash at end of period | 278.74 Million | 288.43 Million | 696.14 Million | 696.14 Million | 360.79 Million | 382.92 Million |
| Capital Expenditure | -2.39 Million | -3.16 Million | -7.72 Million | -2.31 Million | -2.53 Million | -1.11 Million |
| Effect of forex changes on cash | - | - | -1.29 Million | -640 Thousand | - | - |
| Net cash flow / Change in cash | -12.71 Million | -407.71 Million | 534.73 Million | 337.74 Million | -22.13 Million | -46.03 Million |
| Free Cash Flow | -130.56 Million | -163.72 Million | -358.3 Million | -122.88 Million | -103.03 Million | -68.24 Million |
UMI
SER
ZENSARTECH
MSP
TINS
JCGI